Linked CD4+/CD8+ T cell neoantigen vaccination overcomes immune checkpoint blockade resistance and enables tumor regression.
Dolina JS, Lee J, Brightman SE, McArdle S, Hall SM, Thota RR, Zavala KS, Lanka M, Ramamoorthy Premlal AL, Greenbaum JA, Cohen EEW, Peters B, Schoenberger SP.
Dolina JS, et al. Among authors: zavala ks.
J Clin Invest. 2023 Sep 1;133(17):e164258. doi: 10.1172/JCI164258.
J Clin Invest. 2023.
PMID: 37655661
Free PMC article.